Literature DB >> 22411240

Juvenile neuronal ceroid lipofuscinoses.

Shiyao Wang1.   

Abstract

Juvenile neuronal ceroid lipofuscinoses (JNCL) is the most common type of the neuronal ceroid lipofuscinoses (NCLs), a group of pediatric neurodegenerative diseases. In this chapter the genetic and biochemical basis, pathogenesis, clinical features, histopathological features, diagnosis and therapeutic strategies of the JNCL are reviewed. The premature death of the patients and subnormal life quality are inevitable due to the lack of understanding of pathogenesis and limitation in treatment. Hence we are still a long way to conquer the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411240     DOI: 10.1007/978-1-4614-0653-2_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Intravenous injections in neonatal mice.

Authors:  Sara E Gombash Lampe; Brian K Kaspar; Kevin D Foust
Journal:  J Vis Exp       Date:  2014-11-11       Impact factor: 1.355

2.  Characterizing upper limb function in the context of activities of daily living in CLN3 disease.

Authors:  Hanna Hildenbrand; Jordan Wickstrom; Rebecca Parks; Cris Zampieri; Thuy-Tien Nguyen; Audrey Thurm; Kisha Jenkins; Katharine E Alter; Jesse Matsubara; Dylan Hammond; Ariane Soldatos; Forbes D Porter; An N Dang Do
Journal:  Am J Med Genet A       Date:  2021-02-08       Impact factor: 2.578

3.  Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).

Authors:  Maria Burkovetskaya; Nikolay Karpuk; Juan Xiong; Megan Bosch; Michael D Boska; Hideyuki Takeuchi; Akio Suzumura; Tammy Kielian
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

4.  Developmental Comparison of Ceramide in Wild-Type and Cln3 Δex7/8 Mouse Brains and Sera.

Authors:  Sally El-Sitt; Jihane Soueid; Jamal Al Ali; Joelle Makoukji; Nadine J Makhoul; Hayat Harati; Rose-Mary Boustany
Journal:  Front Neurol       Date:  2019-02-19       Impact factor: 4.003

5.  Special Issue on "Sphingolipids: From Pathology to Therapeutic Perspectives".

Authors:  Gerhild van Echten-Deckert
Journal:  Cells       Date:  2020-11-03       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.